Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,969
Showing 50 of 1,969
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 51 | ANTX | An2 Therapeutics, Inc. | 127/139 | 20 | 88% | +68.4% | +93.3% | +94.0% | -308.5% |
| 52 | FTCI | Ftc Solar, Inc. | 144/149 | 12 | 99% | +68.1% | +81.9% | +90.8% | -37.1% |
| 53 | MGNX | MacRogenics Inc | 19 | 6 | 95% | +68.1% | +88.7% | +94.0% | -218.4% |
| 54 | ACRS | Aclaris Therapeutics, Inc. | 30/31 | 7 | 90% | +67.5% | +90.2% | +92.9% | -8.8% |
| 55 | BOXL | Boxlight Corp | 86/91 | 8 | 100% | +67.3% | +69.0% | +93.1% | +5.2% |
| 56 | OM | Outset Medical, Inc. | 191/213 | 10 | 96% | +66.4% | +74.7% | +96.2% | -39.3% |
| 57 | LWLG | Lightwave Logic, Inc. | 34/49 | 8 | 100% | +66.1% | +70.7% | +72.4% | +12.8% |
| 58 | LGVN | Longeveron Inc. | 15 | 4 | 100% | +65.6% | +60.7% | +95.3% | +37.1% |
| 59 | CHGG | Chegg, Inc | 12/13 | 4 | 100% | +65.2% | +66.0% | +81.4% | +43.6% |
| 60 | PROP | Prairie Operating Co. | 57/61 | 9 | 100% | +64.8% | +64.8% | +69.6% | +35.0% |
| 61 | CHPT | Chargepoint Holdings, Inc. | 335/351 | 24 | 100% | +64.3% | +64.1% | +83.6% | +17.9% |
| 62 | BRBR | Bellring Brands, Inc. | 26/43 | 6 | 88% | +64.1% | +75.7% | +86.8% | -66.8% |
| 63 | FATE | Fate Therapeutics Inc | 76/82 | 16 | 96% | +63.1% | +81.5% | +88.9% | -30.6% |
| 64 | PMVP | Pmv Pharmaceuticals, Inc. | 22/30 | 9 | 100% | +62.8% | +77.0% | +77.8% | +18.5% |
| 65 | TPHS | Trinity Place Holdings Inc. | 21 | 3 | 100% | +62.2% | +67.5% | +71.0% | +45.4% |
| 66 | ORGN | Origin Materials, Inc. | 29/38 | 8 | 86% | +62.2% | +79.9% | +90.2% | -32.5% |
| 67 | PTN | Palatin Technologies Inc | 13/14 | 3 | 100% | +62.0% | +55.9% | +89.3% | +54.2% |
| 68 | SSNT | Silversun Technologies, Inc. | 48/54 | 10 | 75% | +61.7% | +89.2% | +91.4% | -41.8% |
| 69 | ADV | Advantage Solutions Inc. | 12 | 6 | 100% | +61.7% | +58.8% | +71.4% | +56.3% |
| 70 | VRCA | Verrica Pharmaceuticals Inc. | 33 | 5 | 88% | +61.4% | +76.8% | +90.6% | -46.8% |
| 71 | TTGT | Techtarget Inc | 19 | 6 | 100% | +61.3% | +76.9% | +78.5% | +18.2% |
| 72 | ZNTL | Zentalis Pharmaceuticals, Inc. | 136/147 | 17 | 98% | +60.5% | +60.8% | +90.2% | -67.9% |
| 73 | SONM | Sonim Technologies Inc | 16/18 | 8 | 88% | +60.4% | +84.9% | +85.0% | -105.7% |
| 74 | ATER | Aterian, Inc. | 31/39 | 11 | 100% | +60.3% | +66.0% | +78.8% | +19.4% |
| 75 | SRPT | Sarepta Therapeutics, Inc. | 28/30 | 8 | 96% | +60.0% | +84.8% | +89.0% | -33.6% |
| 76 | DCGO | Docgo Inc. | 22/23 | 7 | 100% | +59.5% | +64.7% | +79.6% | +23.4% |
| 77 | TNDM | Tandem Diabetes Care Inc | 23/25 | 7 | 100% | +59.3% | +63.4% | +70.3% | +25.2% |
| 78 | LVWR | Livewire Group, Inc. | 20/35 | 7 | 100% | +59.3% | +81.2% | +85.2% | +11.5% |
| 79 | RNAC | Cartesian Therapeutics, Inc. | 29/55 | 9 | 100% | +59.2% | +59.0% | +67.7% | +56.2% |
| 80 | LPSN | Liveperson Inc | 46/74 | 14 | 96% | +58.6% | +73.3% | +89.5% | -39.2% |
| 81 | HTCR | Heartcore Enterprises, Inc. | 29 | 3 | 100% | +58.2% | +54.8% | +77.9% | +44.4% |
| 82 | STEM | Stem, Inc. | 93/105 | 17 | 94% | +57.8% | +72.7% | +92.2% | -35.7% |
| 83 | MCB | Metropolitan Bank Holding Corp. | 176/215 | 11 | 90% | +57.4% | +67.2% | +75.4% | -53.3% |
| 84 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 17/30 | 9 | 82% | +57.3% | +81.0% | +82.6% | -14.9% |
| 85 | ZI | Zoominfo Technologies Inc. | 758/789 | 23 | 100% | +56.8% | +59.1% | +64.2% | -11.5% |
| 86 | PRTS | Carparts.com, Inc. | 10 | 4 | 100% | +56.7% | +68.2% | +75.3% | +21.8% |
| 87 | FDMT | 4d Molecular Therapeutics, Inc. | 48/59 | 13 | 83% | +56.4% | +70.4% | +90.1% | -52.5% |
| 88 | PTLO | Portillo'S Inc. | 49 | 14 | 94% | +56.2% | +69.2% | +69.2% | -13.4% |
| 89 | KLRS | Kalaris Therapeutics, Inc. | 91/148 | 7 | 97% | +55.7% | +61.7% | +85.9% | -11.8% |
| 90 | RBOT | Vicarious Surgical Inc. | 119/134 | 7 | 89% | +55.5% | +74.9% | +91.5% | -49.1% |
| 91 | VIR | Vir Biotechnology, Inc. | 334/433 | 19 | 95% | +55.1% | +62.5% | +71.5% | -72.4% |
| 92 | QTRX | Quanterix Corp | 43 | 7 | 93% | +54.3% | +61.4% | +74.6% | -52.7% |
| 93 | AEYE | Audioeye Inc | 17 | 4 | 100% | +54.0% | +55.4% | +55.9% | +44.0% |
| 94 | SYBX | Synlogic, Inc. | 10/11 | 4 | 90% | +53.8% | +64.4% | +79.8% | -21.2% |
| 95 | BIRD | Allbirds, Inc. | 24/32 | 6 | 100% | +53.8% | +54.6% | +69.0% | +33.5% |
| 96 | RENT | Rent the Runway, Inc. | 259/276 | 13 | 91% | +53.4% | +58.3% | +89.3% | -9.4% |
| 97 | EZFL | Ezfill Holdings Inc | 31/43 | 5 | 100% | +53.0% | +51.8% | +58.9% | +48.7% |
| 98 | BLNK | Blink Charging Co. | 67 | 3 | 100% | +52.8% | +53.5% | +68.1% | +16.0% |
| 99 | NOTE | Fiscalnote Holdings, Inc. | 133/149 | 9 | 93% | +52.7% | +54.7% | +97.8% | -35.6% |
| 100 | RPD | Rapid7, Inc. | 34/41 | 8 | 100% | +52.6% | +52.5% | +77.3% | +23.9% |